Jennifer Cocohoba, PharmD

Email Jennifer
(415) 514-0892

533 Parnassus Avenue
San Francisco, CA 94117

Visit CTSI Profile

  • Professor, UCSF School of Pharmacy

Biography

Dr. Cocohoba is Professor of Clinical Pharmacy in the Department of Clinical Pharmacy at the University of California San Francisco. Dr. Cocohoba specializes in HIV/AIDS Ambulatory Care. She serves as the clinical pharmacist responsible for developing and maintaining the treatment adherence program at the UCSF Womens’ HIV Program (WHP). She also serves as a faculty advisor and research mentor for the UCSF student-run free clinic, the Mabuhay Health Center. Dr. Cocohoba conducts research on pharmacy-based interventions to improve adherence to HIV antiretroviral medicines, antiretroviral therapy concordance with national treatment guidelines, sex-related HIV treatment disparities, and on health of Filipino-Americans.

Displaying 1 - 36 of 36

  1. Chandran A, Benning L, Musci RJ, Wilson TE, Milam J, Adedimeji A, Parish C, Adimora AA, Cocohoba J, Cohen MH, Holstad M, Kassaye S, Kempf MC, Golub ET. The Longitudinal Association between Social Support on HIV Medication Adherence and Healthcare Utilization in the Women's Interagency HIV Study. AIDS Behav. 2018 Oct 11. View on Pubmed
  2. Mills JC, Pence BW, Todd JV, Bengtson AM, Breger TL, Edmonds A, Cook RL, Adedimeji A, Schwartz RM, Kassaye S, Milam J, Cocohoba J, Cohen M, Golub E, Neigh G, Fischl M, Kempf MC, Adimora AA. Cumulative Burden of Depression and All-Cause Mortality in Women Living with HIV. Clin Infect Dis. 2018 Mar 30. View on Pubmed
  3. Ly W, Cocohoba J, Chyorny A, Halpern J, Auerswald C, Myers J. Perspectives on Integrated Hiv and Hcv Testing Among Persons Entering A Northern California Jail: A Pilot Study. J Acquir Immune Defic Syndr. 2018 Feb 22. View on Pubmed
  4. Todd JV, Cole SR, Wohl DA, Simpson RJ, Jonsson Funk M, Brookhart MA, Cocohoba J, Merenstein D, Sharma A, Lazar J, Milam J, Cohen M, Gange S, Lewis TT, Burkholder G, Adimora AA. Underutilization of Statins When Indicated in HIV-Seropositive and Seronegative Women. AIDS Patient Care STDS. 2017 Nov; 31(11):447-454. View on Pubmed
  5. Dong BJ, Lopez M, Cocohoba J. Pharmacists performing hepatitis C antibody point-of-care screening in a community pharmacy: A pilot project. J Am Pharm Assoc (2003). 2017 Jul - Aug; 57(4):510-515.e2. View on Pubmed
  6. Ludema C, Cole SR, Eron JJ, Holmes GM, Anastos K, Cocohoba J, Cohen MH, Cooper HLF, Golub ET, Kassaye S, Konkle-Parker D, Metsch L, Milam J, Wilson TE, Adimora AA. Health Insurance Type and Control of Hypertension Among US Women Living With and Without HIV Infection in the Women's Interagency HIV Study. Am J Hypertens. 2017 Jun 01; 30(6):594-601. View on Pubmed
  7. Empson S, Cuca YP, Cocohoba J, Dawson-Rose C, Davis K, Machtinger EL. Seeking Safety Group Therapy for Co-Occurring Substance Use Disorder and PTSD among Transgender Women Living with HIV: A Pilot Study. J Psychoactive Drugs. 2017 Sep-Oct; 49(4):344-351. View on Pubmed
  8. Ludema C, Cole SR, Eron JJ, Edmonds A, Holmes GM, Anastos K, Cocohoba J, Cohen M, Cooper HL, Golub ET, Kassaye S, Konkle-Parker D, Metsch L, Milam J, Wilson TE, Adimora AA. Impact of Health Insurance, ADAP, and Income on HIV Viral Suppression Among US Women in the Women's Interagency HIV Study, 2006-2009. J Acquir Immune Defic Syndr. 2016 11 01; 73(3):307-312. View on Pubmed
  9. Hanna DB, Jung M, Xue X, Anastos K, Cocohoba JM, Cohen MH, Golub ET, Hessol NA, Levine AM, Wilson TE, Young MA, Kaplan RC. Trends in Nonlipid Cardiovascular Disease Risk Factor Management in the Women's Interagency HIV Study and Association with Adherence to Antiretroviral Therapy. AIDS Patient Care STDS. 2016 Oct; 30(10):445-454. View on Pubmed
  10. Cocohoba J. Pharmacists caring for transgender persons. Am J Health Syst Pharm. 2017 02 01; 74(3):170-174. View on Pubmed
  11. Corelli RL, Muchnik MA, Beechinor RJ, Fong G, Vogt EM, Cocohoba JM, Tsourounis C, Hudmon KS. Perceptions and Cost-Analysis of a Multiple Mini-Interview in a Pharmacy School Admissions Process. Am J Pharm Educ. 2015 Nov 25; 79(9):135. View on Pubmed
  12. Cook JA, Burke-Miller JK, Grey DD, Cocohoba J, Liu C, Schwartz RM, Golub ET, Anastos K, Steigman PJ, Cohen MH. Do HIV-positive women receive depression treatment that meets best practice guidelines? AIDS Behav. 2014 Jun; 18(6):1094-102. View on Pubmed
  13. Hanna DB, Hessol NA, Golub ET, Cocohoba JM, Cohen MH, Levine AM, Wilson TE, Young M, Anastos K, Kaplan RC. Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women. J Acquir Immune Defic Syndr. 2014 Apr 15; 65(5):587-96. View on Pubmed
  14. Cocohoba J, Dong BJ, Johnson MO, Saberi P. Reporting of critical information in studies of pharmacists in HIV care. Int J Pharm Pract. 2014 Dec; 22(6):375-85. View on Pubmed
  15. Cocohoba J, Comfort M, Kianfar H, Johnson MO. A qualitative study examining HIV antiretroviral adherence counseling and support in community pharmacies. J Manag Care Pharm. 2013 Jul-Aug; 19(6):454-60. View on Pubmed
  16. Cocohoba JM, Murphy P, Pietrandoni G, Guglielmo BJ. Improved antiretroviral refill adherence in HIV-focused community pharmacies. J Am Pharm Assoc (2003). 2012 Sep-Oct; 52(5):e67-73. View on Pubmed
  17. Murphy P, Cocohoba J, Tang A, Pietrandoni G, Hou J, Guglielmo BJ. Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy. AIDS Patient Care STDS. 2012 Sep; 26(9):526-31. View on Pubmed
  18. Cocohoba JM, Althoff KN, Cohen M, Hu H, Cunningham CO, Sharma A, Greenblatt RM. Pharmacist counseling in a cohort of women with HIV and women at risk for HIV. Patient Prefer Adherence. 2012; 6:457-63. View on Pubmed
  19. Saberi P, Dong BJ, Johnson MO, Greenblatt RM, Cocohoba JM. The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review. Patient Prefer Adherence. 2012; 6:297-322. View on Pubmed
  20. Sherman EM, Cocohoba JM, Neff SE, Dong BJ. Health care provider satisfaction with telephone consultations provided by pharmacists and physicians at the National HIV/AIDS Clinicians' Consultation Center. Ann Pharmacother. 2011 Dec; 45(12):1499-505. View on Pubmed
  21. Cocohoba J. Making sense of side effects. BETA. 2011 Fall-Winter; 23(4):19-29. View on Pubmed
  22. Cocohoba JM, Althoff KN, Godfrey R, Palella FJ, Greenblatt RM. Influence of gender on receipt of guideline-based antiretroviral therapy in the era of HAART. AIDS Care. 2012; 24(1):20-9. View on Pubmed
  23. Lao CK, Gruta C, John MD, Cocohoba J. A comparison of tenofovir-associated renal function changes in HIV-infected African Americans vs Caucasians. J Natl Med Assoc. 2011 Jun; 103(6):518-22. View on Pubmed
  24. Yi T, Cocohoba J, Cohen M, Anastos K, DeHovitz JA, Kono N, Hanna DB, Hessol NA. The impact of the AIDS Drug Assistance Program (ADAP) on use of highly active antiretroviral and antihypertensive therapy among HIV-infected women. J Acquir Immune Defic Syndr. 2011 Mar 01; 56(3):253-62. View on Pubmed
  25. Cocohoba J, Hsu T, Greenblatt RM. Community Pharmacy Use Patterns of Women with HIV and Women At Risk for HIV in the San Francisco Bay Area. J Pharm Technol. 2010 Sep-Oct; 26(5):271-275. View on Pubmed
  26. Cocohoba J. Hormonal contraception for HIV positive women. BETA. 2010 Winter-Spring; 22(2):36-40. View on Pubmed
  27. Cocohoba J. The SWITCHMRK studies: substitution of lopinavir/ritonavir with raltegravir in HIV-positive individuals. Expert Rev Anti Infect Ther. 2009 Dec; 7(10):1159-63. View on Pubmed
  28. Cocohoba J, Ramay B, Patterson S. HIV postexposure prophylaxis availability in U.S. rural hospitals. Am J Health Syst Pharm. 2008 Oct 01; 65(19):1796-7. View on Pubmed
  29. Cocohoba J, Dong BJ. Raltegravir: the first HIV integrase inhibitor. Clin Ther. 2008 Oct; 30(10):1747-65. View on Pubmed
  30. El-Ibiary SY, Cocohoba JM. Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives. Eur J Contracept Reprod Health Care. 2008 Jun; 13(2):123-32. View on Pubmed
  31. Cocohoba J, Wang QJ, Cox C, Gange SJ, Cohen M, Glesby M, DeHovitz JA, Greenblatt RM. Consistency of initial antiretroviral therapy with HIV treatment guidelines in a US cohort of HIV-infected women. J Acquir Immune Defic Syndr. 2008 Mar 01; 47(3):377-83. View on Pubmed
  32. Robinson CA, Cocohoba J, MacDougall C, John MD, Guglielmo BJ. Discordance between ambulatory care clinic and community pharmacy medication databases for HIV-positive patients. J Am Pharm Assoc (2003). 2007 Sep-Oct; 47(5):613-5. View on Pubmed
  33. El-Ibiary S, Cocohoba J. Refusals by pharmacists to dispense emerging contraception: a critique. Obstet Gynecol. 2006 Sep; 108(3 Pt 1):692; author reply 692-3. View on Pubmed
  34. Dong BJ, Cocohoba JM. Tipranavir: a protease inhibitor for HIV salvage therapy. Ann Pharmacother. 2006 Jul-Aug; 40(7-8):1311-21. View on Pubmed
  35. Graves D, Cocohoba J, Gruta C, Goldschmidt R. Potential adverse effects and inferior efficacy in ARV treatment. J Natl Med Assoc. 2004 May; 96(5):692-3; author reply 693. View on Pubmed
  36. Cocohoba JM, McNicholl IR. Valganciclovir: an advance in cytomegalovirus therapeutics. Ann Pharmacother. 2002 Jun; 36(6):1075-9. View on Pubmed